Comprehensive handbook for developing a bladder cancer cystectomy database.
暂无分享,去创建一个
Y. Lotan | S. Boorjian | N. Smith | T. Guzzo | S. Shariat | P. Clark | A. Kamat | M. Nielsen | J. Gingrich | B. Inman | R. Svatek | M. Droller | Jennifer M. Taylor | G. Amiel | L. Karsh
[1] M. Mi,et al. Flavonoids, Flavonoid Subclasses and Breast Cancer Risk: A Meta-Analysis of Epidemiologic Studies , 2013, PloS one.
[2] L. Kiemeney,et al. Discrepancy between clinical staging through bimanual palpation and pathological staging after cystectomy. , 2012, Urologic oncology.
[3] M. Khochikar. EARLY VS DELAYED RADICAL CYSTECTOMY FOR ‘HIGH‐RISK’ CARCINOMA NOT INVADING BLADDER MUSCLE: DELAY OF CYSTECTOMY REDUCES CANCER‐SPECIFIC SURVIVAL , 2011, BJU international.
[4] Y. Lotan,et al. Management of elderly patients with urothelial carcinoma of the bladder: guideline concordance and predictors of overall survival , 2010, BJU international.
[5] W. Sexton,et al. Bladder cancer: a review of non-muscle invasive disease. , 2010, Cancer control : journal of the Moffitt Cancer Center.
[6] A. Jemal,et al. Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.
[7] J. Kaouk,et al. Surgical margin status after robot assisted radical cystectomy: results from the International Robotic Cystectomy Consortium. , 2010, The Journal of urology.
[8] J. Epstein. Diagnosis and Classification of Flat, Papillary, and Invasive Urothelial Carcinoma: The WHO/ISUP Consensus , 2010, International journal of surgical pathology.
[9] Sanjay G. Patel,et al. Preoperative hydronephrosis predicts extravesical and node positive disease in patients undergoing cystectomy for bladder cancer. , 2010, The Journal of urology.
[10] U. Capitanio,et al. International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy , 2010, BJU international.
[11] U. Capitanio,et al. Soft tissue surgical margin status is a powerful predictor of outcomes after radical cystectomy: a multicenter study of more than 4,400 patients. , 2009, The Journal of urology.
[12] A. Shabsigh,et al. Analysis of gender differences in early perioperative complications following radical cystectomy at a tertiary cancer center using a standardized reporting methodology. , 2010, Urologic oncology.
[13] Y. Lotan,et al. Perioperative intravesical therapy after transurethral resection for bladder cancer. , 2010, The Journal of urology.
[14] A. Bohle. An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus Calmette-Guérin for non-muscle-invasive bladder cancer , 2009 .
[15] P. Fayers,et al. Quality of life and body image for bladder cancer patients undergoing radical cystectomy and urinary diversion--a prospective cohort study with a systematic review of literature. , 2009, Urology.
[16] G. Ergun,et al. Prognostic Significance of Hydronephrosis in Bladder Cancer Treated by Radical Cystectomy , 2009, Urologia Internationalis.
[17] R. Bahnson,et al. Preoperative hydronephrosis as an indicator of survival after radical cystectomy. , 2009, Urologic oncology.
[18] R. Autorino,et al. Health related quality of life after radical cystectomy: comparison of ileal conduit to continent orthotopic neobladder. , 2009, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[19] J. Witjes,et al. An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus Calmette-Guérin for non-muscle-invasive bladder cancer. , 2009, European urology.
[20] P. Javlé,et al. Orthotopic neobladder versus ileal conduit urinary diversion after cystectomy--a quality-of-life based comparison. , 2009, Annals of the Royal College of Surgeons of England.
[21] B. Konety,et al. The significance of lymphovascular invasion in transurethral resection of bladder tumour and cystectomy specimens on the survival of patients with urothelial bladder cancer , 2009, BJU international.
[22] B. Bochner,et al. Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology. , 2009, European urology.
[23] S. Baltacı,et al. Computerized Tomography for Detecting Perivesical Infiltration and Lymph Node Metastasis in Invasive Bladder Carcinoma , 2008, Urologia Internationalis.
[24] H. Herr,et al. Quality control in transurethral resection of bladder tumours , 2008, BJU international.
[25] J. Montie,et al. Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens. , 2008, The Journal of urology.
[26] H. Herr. Is maintenance Bacillus Calmette-Guérin really necessary? , 2008, European urology.
[27] T. Guzzo,et al. Hydronephrosis is an independent predictor of poor clinical outcome in patients treated for muscle-invasive transitional cell carcinoma with radical cystectomy. , 2008, Urology.
[28] A. Vickers,et al. Age‐adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer , 2008, Cancer.
[29] A. Tizzani,et al. Morbidity and quality of life in elderly patients receiving ileal conduit or orthotopic neobladder after radical cystectomy for invasive bladder cancer. , 2008, Urology.
[30] J. Witjes,et al. Comparison of three schedules of intravesical epirubicin in patients with non-muscle-invasive bladder cancer. , 2008, European urology.
[31] L. Elting,et al. Gender and age differences in blood utilization and length of stay in radical cystectomy: a population-based study , 2008, International Urology and Nephrology.
[32] Y. Lotan,et al. Outcomes of patients with clinical T1 grade 3 urothelial cell bladder carcinoma treated with radical cystectomy. , 2008, Urology.
[33] H. Hricak,et al. Bladder cancer: can imaging change patient management? , 2008, Current opinion in urology.
[34] B. Konety,et al. A DELAY IN RADICAL CYSTECTOMY OF >3 MONTHS IS NOT ASSOCIATED WITH A WORSE CLINICAL OUTCOME , 2007, BJU international.
[35] Kevin C Zorn,et al. The Will Rogers phenomenon in urological oncology. , 2008, The Journal of urology.
[36] K. Kavanagh,et al. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival. , 2007, The Journal of urology.
[37] A. Zlotta. When and how to treat superficial and muscle-invasive bladder cancer. , 2007, European urology.
[38] C. Dinney,et al. P0 stage at radical cystectomy for bladder cancer is associated with improved outcome independent of traditional clinical risk factors. , 2007, European urology.
[39] E. Wallen,et al. Incidence and risk factors of stomal complications in patients undergoing cystectomy with ileal conduit urinary diversion for bladder cancer. , 2007, The Journal of urology.
[40] C. Klabunde,et al. A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients. , 2007, Annals of epidemiology.
[41] M. Tinetti,et al. The impact of chronic illnesses on the use and effectiveness of adjuvant chemotherapy for colon cancer , 2007, Cancer.
[42] W. See. Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer , 2007 .
[43] John T. Wei,et al. Measuring health‐related quality of life outcomes in bladder cancer patients using the Bladder Cancer Index (BCI) , 2007, Cancer.
[44] N. Holalkere,et al. State-of-the-art cross-sectional imaging in bladder cancer. , 2007, Current problems in diagnostic radiology.
[45] J. Wright,et al. Quality-of-life assessment in patients with bladder cancer , 2007, Nature Clinical Practice Urology.
[46] R. Kuefer,et al. Hydronephrosis as a prognostic marker in bladder cancer in a cystectomy-only series. , 2007, European urology.
[47] S. Donat. Standards for surgical complication reporting in urologic oncology: time for a change. , 2007, Urology.
[48] J. Stein,et al. Surgical benchmarks for the treatment of invasive bladder cancer. , 2007, Urologic oncology.
[49] Jingbo Zhang,et al. Imaging of bladder cancer. , 2007, Radiologic clinics of North America.
[50] A. Jemal,et al. Cancer Statistics, 2007 , 2007, CA: a cancer journal for clinicians.
[51] Yair Lotan,et al. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium. , 2006, The Journal of urology.
[52] Y. Lotan,et al. Precystectomy nomogram for prediction of advanced bladder cancer stage. , 2006, European urology.
[53] A. Vickers,et al. Standardization of pelvic lymphadenectomy performed at radical cystectomy , 2006, Cancer.
[54] Yair Lotan,et al. Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder. , 2006, The Journal of urology.
[55] Núria Malats,et al. Smoking and Bladder Cancer in Spain: Effects of Tobacco Type, Timing, Environmental Tobacco Smoke, and Gender , 2006, Cancer Epidemiology Biomarkers & Prevention.
[56] R. Dunn,et al. Cystectomy delay more than 3 months from initial bladder cancer diagnosis results in decreased disease specific and overall survival. , 2006, The Journal of urology.
[57] J. Thüroff,et al. Lymph Node Metastases in Non-Muscle Invasive Bladder Cancer are Correlated With the Number of Transurethral Resections and Tumour Upstaging at Radical Cystectomy , 2006 .
[58] S. Joniau,et al. Clinical experience with the N-shaped ileal neobladder: assessment of complications, voiding patterns, and quality of life in our series of 58 patients. , 2006, European urology.
[59] K. Shigeno,et al. Health related quality of life after orthotopic neobladder construction and its comparison with normative values in the Japanese population. , 2005, The Journal of urology.
[60] R. Havlik,et al. Age and comorbidity impact surgical therapy in older bladder carcinoma patients , 2005, Cancer.
[61] Yair Lotan,et al. Lymphovascular Invasion Is Independently Associated With Overall Survival, Cause-Specific Survival, and Local and Distant Recurrence in Patients With Negative Lymph Nodes at Radical Cystectomy , 2005 .
[62] C. Vale. Neoadjuvant Chemotherapy in Invasive Bladder Cancer: Update of a Systematic Review and Meta-Analysis of Individual Patient Data: Advanced Bladder Cancer (ABC) Meta-analysis Collaboration , 2005 .
[63] M. Parmar,et al. Adjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis of individual patient data Advanced Bladder Cancer (ABC) Meta-analysis Collaboration. , 2005, European urology.
[64] J. Witjes,et al. Bacillus calmette-guerin versus chemotherapy for the intravesical treatment of patients with carcinoma in situ of the bladder: a meta-analysis of the published results of randomized clinical trials. , 2005, The Journal of urology.
[65] S. Joniau,et al. Clinical Experience with the N-shaped Ileal Neobladder: Assessment of Complications, Voiding Patterns, and Quality of Life in Our Series of 58 Patients , 2005 .
[66] V. Ficarra,et al. Correlation between clinical and pathological staging in a series of radical cystectomies for bladder carcinoma , 2005, BJU international.
[67] K. Yoshimura,et al. Impact of superficial bladder cancer and transurethral resection on general health-related quality of life: an SF-36 survey. , 2005, Urology.
[68] S. Almenar,et al. The optimum timing of radical cystectomy for patients with recurrent high‐risk superficial bladder tumour , 2004, BJU international.
[69] N. Demartines,et al. Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey , 2004, Annals of Surgery.
[70] H. Grossman,et al. Surgical factors influence bladder cancer outcomes: a cooperative group report. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[71] R. Sylvester,et al. A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials. , 2004, The Journal of urology.
[72] Sam S. Chang,et al. Standardization of radical cystectomy and pelvic lymph node dissection for bladder cancer: a collaborative group report. , 2004, The Journal of urology.
[73] F. Montorsi,et al. Overall clinical outcomes after nerve and seminal sparing radical cystectomy for the treatment of organ confined bladder cancer. , 2004, The Journal of urology.
[74] Gerhard Jakse,et al. A second-look TUR in T1 transitional cell carcinoma: why? , 2004, European urology.
[75] Kathryn E. McGoldrick,et al. Surgeon Volume and Operative Mortality in the United States , 2004 .
[76] A. Böhle,et al. Intravesical bacille Calmette-Guérin versus mitomycin C in superficial bladder cancer: formal meta-analysis of comparative studies on tumor progression. , 2004, Urology.
[77] R. Sylvester,et al. 478 One immediate postoperative instillation of chemotherapy reduces the risk of recurrence in patients with stage TA T1 bladder cancer: A meta-analysis of the published results of randomized clinical trials , 2004 .
[78] J. Overgaard,et al. Early and late treatment‐related morbidity following radical cystectomy , 2004, Scandinavian journal of urology and nephrology.
[79] M. Ghoneim,et al. Secondary malignant involvement of gynecologic organs in radical cystectomy specimens in women: is it mandatory to remove these organs routinely? , 2003, The Journal of urology.
[80] A. Seraji,et al. A comparison between clinical and pathologic staging in patients with bladder cancer. , 2004, Urology journal.
[81] Liang Cheng,et al. Stage pT1 bladder carcinoma: diagnostic criteria, pitfalls and prognostic significance. , 2003, Pathology.
[82] Sam S. Chang,et al. Health related quality of life in patients treated with radical cystectomy and urinary diversion for urothelial carcinoma of the bladder: development and validation of a new disease specific questionnaire. , 2003, The Journal of urology.
[83] Sam S. Chang,et al. Delaying radical cystectomy for muscle invasive bladder cancer results in worse pathological stage. , 2003, The Journal of urology.
[84] P. Grosclaude,et al. Determinants of quality of life of bladder cancer survivors five years after treatment in France , 2003, International journal of urology : official journal of the Japanese Urological Association.
[85] Badrinath R Konety,et al. Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: analysis of data from the Surveillance, Epidemiology and End Results Program data base. , 2003, The Journal of urology.
[86] W. Huang,et al. An interval longer than 12 weeks between the diagnosis of muscle invasion and cystectomy is associated with worse outcome in bladder carcinoma. , 2003, The Journal of urology.
[87] Sam S. Chang,et al. Complications of radical cystectomy for nonmuscle invasive disease: comparison with muscle invasive disease. , 2003, The Journal of urology.
[88] A. Böhle,et al. Intravesical bacillus Calmette-Guerin versus mitomycin C for superficial bladder cancer: a formal meta-analysis of comparative studies on recurrence and toxicity. , 2003, The Journal of urology.
[89] V. Reuter,et al. Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. , 2003, The Journal of urology.
[90] B. Guillonneau,et al. Cystectomy with prostate sparing for bladder cancer in 100 patients: 10-year experience. , 2002, The Journal of urology.
[91] D. Lamm,et al. Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials. , 2002, The Journal of urology.
[92] J. Birkmeyer,et al. Hospital volume and surgical mortality in the United States. , 2002, The New England journal of medicine.
[93] Robert C. G. Martin,et al. Quality of Complication Reporting in the Surgical Literature , 2002, Annals of surgery.
[94] Sam S. Chang,et al. Analysis of early complications after radical cystectomy: results of a collaborative care pathway. , 2002, The Journal of urology.
[95] H. Miyake,et al. Health‐related quality of life after radical cystectomy for bladder cancer: a comparison of ileal conduit and orthotopic bladder replacement , 2002, BJU international.
[96] H. Miyake,et al. Health-related quality of life after radical cystectomy for bladder cancer: a comparison of ileal conduit and orthotopic bladder replacement , 2002 .
[97] S. Groshen,et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[98] J L Warren,et al. Development of a comorbidity index using physician claims data. , 2000, Journal of clinical epidemiology.
[99] G. Bartsch,et al. Quality of life after cystectomy and orthotopic neobladder versus ileal conduit urinary diversion , 2000, World Journal of Urology.
[100] E Dorant,et al. The impact of characteristics of cigarette smoking on urinary tract cancer risk , 2000, Cancer.
[101] M. Resnick,et al. Limitations of computerized tomography in staging invasive bladder cancer before radical cystectomy. , 2000, The Journal of urology.
[102] D. Lamm,et al. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study. , 2000, The Journal of urology.
[103] D J Rosario,et al. The changing pattern of mortality and morbidity from radical cystectomy , 2000, BJU international.
[104] Lawrence D. True,et al. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder , 1998 .
[105] M. Droller,et al. Bladder cancer: State‐of‐the‐art care , 1998, CA: a cancer journal for clinicians.
[106] F. Mostofi,et al. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. , 1998, The American journal of surgical pathology.
[107] Luc Bijnens,et al. A combined analysis of European Organization for Research and Treatment of Cancer and Medical Research Council randomized clinical trials for the prophylactic treatment of stage TaT1 bladder cancer , 1996 .
[108] S. Fosså,et al. Clinical significance of routine pre-cystectomy bone scans in patients with muscle-invasive bladder cancer. , 1996, British journal of urology.
[109] W. Fair,et al. Intravesical bacillus Calmette-Guérin therapy prevents tumor progression and death from superficial bladder cancer: ten-year follow-up of a prospective randomized trial. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[110] J. Barentsz,et al. Staging urinary bladder cancer: value of T1-weighted three-dimensional magnetization prepared-rapid gradient-echo and two-dimensional spin-echo sequences. , 1995, AJR. American journal of roentgenology.
[111] D. Tulsky,et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[112] R. Deyo,et al. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. , 1992, Journal of clinical epidemiology.
[113] C. Sherbourne,et al. The MOS 36-Item Short-Form Health Survey (SF-36) , 1992 .
[114] J. Sanabria,et al. Proposed classification of complications of surgery with examples of utility in cholecystectomy. , 1992, Surgery.
[115] J. Dunn,et al. Neo-adjuvant (pre-emptive) cisplatin therapy in invasive transitional cell carcinoma of the bladder. , 1991, British journal of urology.
[116] F. Marshall,et al. Local recurrence and survival following nerve-sparing radical cystoprostatectomy. , 1990, The Journal of urology.
[117] C. Mackenzie,et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.
[118] Gregory Spencer,et al. Projections of the Population of the United States, by Age, Sex, and Race: 1983 to 2080. , 1984 .